SCHEMBL10061698

SCHEMBL10061698

C=C1Nc2ccccc2C(C)(C)N1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.44
PDK4 Q16654 1/20 0.44
HTR5A P47898 2/20 0.40
AKR1B1 P15121 4/20 0.36
KMT2A Q03164 5/20 0.34
MEN1 O00255 3/20 0.34
ALDH1A1 P00352 4/20 0.33
HSD17B10 Q99714 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
LMNA P02545 2/20 0.33
CYP3A4 P08684 1/20 0.33
PDE7A Q13946 1/20 0.33
KDM4E B2RXH2 3/20 0.33
HPGD P15428 2/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
RUNX1 Q01196 1/20 0.33
CBFB Q13951 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22010250 0.80 PDK2 (0.46) PDK2PDK4HTR5AAKR1B1KMT2A
SCHEMBL25365206 0.75 PDK2 (0.44) PDK2PDK4HTR5AAKR1B1KMT2A
SCHEMBL14501652 0.75 PDK2 (0.59) PDK2PDK4HTR5AAKR1B1KMT2A
SCHEMBL30242138 0.70 PDK2 (0.57) PDK2PDK4HTR5AAKR1B1KMT2A
SCHEMBL844744 0.70 PDK2 (0.57) PDK2PDK4HTR5AAKR1B1KMT2A
SCHEMBL6878925 0.69 NOX1 (0.42) PDK2KMT2AMEN1ALDH1A1TDP1
SCHEMBL21662876 0.68 ALDH1A1 (0.47) PDK2PDK4HTR5AKMT2AMEN1
SCHEMBL31911 0.67 PDK2 (0.67) PDK2PDK4HTR5AAKR1B1KMT2A
SCHEMBL29371027 0.67 PDK2 (0.67) PDK2PDK4HTR5AAKR1B1KMT2A
SCHEMBL16369712 0.67 PDK2 (0.43) PDK2PDK4HTR5AAKR1B1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8207179-B2 Substituted indolines as tyrosine kinase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-26 US disclosed
US-20100222331-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222331-A1 NEW COMPOUNDS CCNA1, CCNY, MKI67 PDK2 473/4885PDK4 733/4885HTR5A 2844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.